Insider Trading History of Doug Rice

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Doug Rice since 2017. This trader's CIK number is 1618861. At the time of last reporting, Doug Rice was the Chief Financial Officer of Mimedx Group, Inc.. (stock ticker symbol MDXG). Also see all insider trading activities at Mimedx Group, Inc..

Note that in the past DOUG RICE also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Mimedx Group, Inc. (MDXG) by Doug Rice

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 MDXG 5,000 $35,785 0 $0 0 $0

Yearly summary of insider trading at Orthofix Medical Inc. (OFIX) by Doug Rice

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 OFIX 1,400 $42,070 0 $0 0 $0
2019 OFIX 0 $0 0 $0 3,937 $0
2018 OFIX 0 $0 10,006 $592,476 0 $0
2017 OFIX 0 $0 7,353 $363,686 0 $0


Insider trading activities at 2 companies by Doug Rice:

1. Mimedx Group, Inc. (MDXG)

2. Orthofix Medical Inc. (OFIX)

Table 1. Insider trading of Mimedx Group, Inc. (MDXG) by Doug Rice

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-11-21 MDXG Buy 5,000 7.16 35,785

Table 2. Insider trading of Orthofix Medical Inc. (OFIX) by Doug Rice

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-11-19 OFIX Buy 1,400 30.05 42,070
2019-07-08 OFIX Option Ex 3,937 .00 0
2018-11-02 OFIX Sale 6,057 61.54 372,723
2018-10-11 OFIX Sale 3,949 55.65 219,753
2017-09-11 OFIX Sale 7,353 49.46 363,686

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doug Rice (Chief Financial Officer of Mimedx Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.